Ondansetron in pregnancy not linked to most birth defects

October 2, 2018

(HealthDay)—Use of ondansetron for the treatment of nausea and vomiting in pregnancy does not appear to be associated with birth defects, according to research published in the August issue of Obstetrics & Gynecology.

Samantha E. Parker, Ph.D., from the Boston University School of Public Health, and colleagues used data from two case-control studies (the National Birth Defects Prevention Study and the Slone Birth Defects Study) to examine the prevalence of ondansetron use for of first-trimester and vomiting during pregnancy. The analyses included 6,751 and 5,873 control mothers, respectively, from each study and 14,667 and 8,533 case mothers who reported first-trimester nausea and vomiting.

The researchers found that ondansetron exposure increased from less than 1 percent before 2000 to 13 percent in 2013 to 2014 among women in the control group. For most of the 51 defect groups analyzed, ondansetron use was not associated with increased risk. In the National Birth Defects Prevention Study, modest increases in risk were seen for cleft palate (adjusted odds ratio, 1.6), while in the Birth Defects Study, there were modest increases for renal agenesis-dysgenesis (adjusted odds ratio, 1.8); however, these findings may be the result of chance.

"For the majority of specific investigated, there was no increased risk associated with first-trimester use of for treatment of nausea and vomiting of pregnancy compared with no treatment, although modest associations with cleft palate and renal agenesis-dysgenesis warrant further study," the authors write.

One author disclosed financial ties to Biogen.

Explore further: Study finds women with pregnancy-related nausea, vomiting use marijuana more

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Study finds women with pregnancy-related nausea, vomiting use marijuana more

August 20, 2018
A Kaiser Permanente study, published today in JAMA Internal Medicine, found that women with mild and severe nausea and vomiting in pregnancy were significantly more likely to have used marijuana during pregnancy than women ...

Study finds no evidence linking anti-nausea drug to birth defects

May 9, 2016
Women suffering from extreme morning sickness often take Zofran (ondansetron) to combat their debilitating nausea and vomiting. However, two studies have found that the drug may increase risk of heart defects and cleft palate ...

Epilepsy drug may not increase risk of birth defects

April 6, 2016
Babies born to pregnant women taking the epilepsy drug lamotrigine may not be at an increased risk of birth defects, such as cleft lip, cleft palate or clubfoot, according to a study published in the April 6, 2016, online ...

Medication taken for nausea during pregnancy not associated with increased risk of major malformations

October 15, 2013
In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, ...

First trimester exposure to antithyroid drugs associated with birth defects

January 22, 2018
Taking antithyroid drugs (ATDs) during the first trimester of pregnancy is associated with an increased risk for birth defects, particularly for women receiving prescriptions for methimazole (MMI) or both MMI and propylthiouracil ...

Effective treatments exist for nausea, vomiting of pregnancy

December 29, 2017
(HealthDay)—Early treatment of nausea and vomiting of pregnancy can prevent complications, according to a Practice Bulletin published online Dec. 21 in Obstetrics & Gynecology.

Recommended for you

Early postpartum opioids linked with persistent usage

December 14, 2018
Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum ...

Hysterectomy linked to memory deficit in an animal model

December 6, 2018
By age 60, one in three American women have had a hysterectomy. Though hysterectomy is a prevalent and routine surgery, the removal of the uterus before natural menopause might actually be problematic for cognitive processes ...

Obesity intervention needed before pregnancy

December 6, 2018
New research from the University of Adelaide's Robinson Research Institute supports the need for dietary and lifestyle interventions before overweight and obese women become pregnant.

First baby born via uterus transplanted from dead donor

December 5, 2018
In a medical first, a mother who received a uterus transplant from a dead donor gave birth to a healthy baby, researchers reported Wednesday.

Researchers find evidence of prenatal environment tuning genomic imprinting

December 5, 2018
A team of researchers from the U.S., Australia and Denmark has found evidence of the prenatal environment tuning genomic imprinting. In their paper published in Proceedings of the National Academy of Sciences, the group describes ...

RSV study reveals age when infants are most vulnerable to asthma

December 5, 2018
New research suggests a maternal vaccination against RSV should be augmented with active immunisation in a child's first two years to reduce the onset of asthma.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.